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Abstract 
Background: Approximately 50 million people (60 %) live in malaria risk areas in Ethiopia, at altitudes below 2000 m. 
According to official data, 60–70 % of malaria cases are due to Plasmodium falciparum, and 40–30 % by Plasmodium 
vivax. The species Plasmodium ovale was detected in 2013 in the northwest of the country, being the first report of 
the presence of this species in Ethiopia since the 60 s. The aim of this study was to assess the diagnosis by microscopy 
and PCR, and demonstrate the presence of other Plasmodium species in the country.
Methods: The survey was conducted in Bulbula, situated in the Rift Valley (West Arsi Province, Oromia Region). From 
December 2010 to October 2011, 3060 samples were collected from patients with symptoms of malaria; the diagnosis 
of malaria was done by microscopy and confirmation by PCR.
Results: 736 samples were positive for malaria by microscopy. After removing the 260 samples (109 positives and 
151 negatives) for which it was not possible to do PCR, there were a total of 2800 samples, 1209 are used for its con-
firmation by PCR and quality control (627 are positives and 582 negatives by microscopy). From the 627 positive sam-
ples, 604 were confirmed as positive by PCR, 23 false positives were detected, and the group of 582 negative samples, 
184 were positive by PCR (false negatives), which added to the previous positive samples is a total of 788, positive 
samples for some species of Plasmodium sp. 13.3 % more positives were detected with the PCR than the microscopy. 
Importantly, 23 samples were detected by PCR as P. ovale, after the sequencing of these samples was determined as P. 
ovale curtisi.
Conclusions: The PCR detected more positive samples than the microscopy; in addition, P. ovale and P. ovale/P. vivax 
were detected that had not been detected by microscopy, which can affect in the infection control.
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Background
Over 60  % of the total Ethiopian population (50–84.2 
million) lives in areas at risk of malaria, generally at ele-
vations below 2000 m above sea level. In 2014, the Fed-
eral Ministry of Health Ethiopia (FMOH) Global Fund 
Concept Note stratified Ethiopian malaria transmission 
risk as follows within 835 districts by population (%) and 
by annual parasite incidence per thousand (API): High 
[>100/1000, 11 million (13  %)]; Medium [5–99.9/1000; 
28.1 million (34  %)], Low [0.1–4.9, 11.1 million (13  %)], 
and Malaria-Free [~0, 33.6 million (40  %)]. According 
to the Federal Ministry of Health Ethiopia (FMOH), in 
2011/2012, malaria was the leading cause of outpatient 
visits, accounting for 17  % of all outpatient visits, and 
8  % of health facility admissions among all age groups. 
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Malaria is one of the top ten causes of inpatient deaths 
among children aged less than 5 years and in older indi-
viduals according to the Health Management Infor-
mation System (HMIS) data. In 2012/2013, there were 
57,503 public sector malaria hospitalizations, 4,984,266 
malaria outpatient cases, and 2,942,031 laboratory-con-
firmed Plasmodium falciparum outpatient malaria cases, 
and 1,258,131 Plasmodium vivax cases according to the 
annual micro-plan [1].
According to official resources the major Plasmodium 
species causing malaria in Ethiopia are P. falciparum 
(about 60 % of cases) and P. vivax (about 40 % of cases), 
with the former being the cause of the most severe clini-
cal manifestations and most deaths [2–4]. Recent thera-
peutic efficacy trials have proven that artemisinin and 
chloroquine have adequate effectiveness for treating 
these pathogens, respectively. To date, major problems 
with emerging drug resistance and counterfeit or sub-
standard anti-malarial drugs have not yet been detected 
in Ethiopia [1]. Control measures established in the area 
where the samples have been collected were established 
by the Ministry of Health of Ethiopia: microscopic diag-
nosis, treatment with artemisinin-based combination 
therapy (ACT), protection with bed nets impregnated 
with insecticide and indoor insecticide spraying.
In general, light microscopy examination of blood 
smears is still considered the “gold standard” for labora-
tory diagnosis of malaria [5]. In many malaria endemic 
regions, however, microscopic diagnosis displays certain 
limitations, such as a shortage of skilled microscopists, 
inadequate quality control [5, 6] and the possibility of 
misdiagnosis due either to low parasitaemia or to mixed 
infections [5, 7, 8]. Moreover, in Ethiopia, as in other 
endemic areas, this method of diagnosis is unavailable to 
the most distant health facilities, for which clinical diag-
nosis is still widely used, leading to cross-diagnosis with 
other diseases [9, 10].
Sometimes it is difficult to determine the species of 
Plasmodium that is detected in the patient by micro-
scopic diagnosis, maybe for lack of training of the micros-
copists, with the consequence that some species are not 
reported in the country, as in the case of Plasmodium 
ovale. This species has a similar morphology to P. vivax, 
and the two may be confused by microscopy. Although 
this does not have implications in the treatment, because 
the patient will receive the same treatment as with P. 
vivax, it has important implications in the malaria epide-
miology and in the malaria parasite distribution. Despite 
the first report of P. ovale in Ethiopia in 1969 [11], the 
knowledge of the distribution and epidemiology of dif-
ferent human malaria species, particularly P. ovale spp., 
and Plasmodium malariae [12] is rather limited in the 
entire country. Alemu et al. [13] detected the presence of 
P. ovale in 2013 in Bahir Dar, a town on Tana Lake, by 
PCR and sequencing—a smilar approach as used in the 
present study.
At present, diagnosis of malaria in reference labora-
tories in non-endemic areas is performed with the aid 
of molecular biology techniques, such as PCR. PCR has 
been confirmed as having a lower detection threshold of 
0.7–0.02 parasites/μl, compared with real time PCR [14, 
15].
The aim of this study was to assess the presence of 
other malaria species, and the capacity of the micros-
copists to detect and identify Plasmodium species. This 
study has used the semi-nested multiplex PCR [16] to 
evaluate the sensitivity and specificity of optical micros-
copy for diagnosis of the Plasmodium infection among all 
patients suspected of having malaria in a health centre of 
a rural area of southeastern Ethiopia
Methods
Survey site, sample collection and microscopy examination
The survey was conducted in Bulbula, a town located in 
West Arsi Province, Oromia Region (Fig. 1). All patients 
who attended the Bulbula Health Centre, with fever 
and suspected of having uncomplicated malaria, were 
included in this study. A total of 3060 samples were col-
lected from suspected malaria patients from December 
2010 to October 2011, with two capillary blood samples, 
one for microscopic diagnosis, and a filter paper (What-
man© 3MM) for diagnostic confirmation by PCR. The 
blood on the filter paper was air dried, then stored in 
double zip-lock plastic bags with silica gel at 4  °C, and 
subsequently transported to the National Centre for 
Tropical Medicine, Institute of Health Carlos III, Madrid 
(Spain) for diagnostic confirmation by PCR. All patients 
signed informed consent forms and the study received 
ethical clearance.
Thin films were stained with 5  % Giemsa solution for 
20 min, and examined by microscopists from the Health 
Centre of Bulbula. The normal protocol for microscopic 
diagnosis was followed, each slide was assessed by two 
microscopists, and, if there was a discrepancy, a third 
microscopist assessed the slide. Parasite density was not 
evaluated because the routine work of health centres in 
rural areas of Ethiopia involves checking for the presence 
or absence of parasites but does not extend to calculating 
parasite densities.
Ethics
Ethical clearance was obtained from the Rural Gen-
eral Hospital of Gambo (West Arsi Province, Oromia 
Region), a hospital which depends on the Health Centre 
of Bulbula. Informed consents forms were obtained from 
each patient or a parental/legal guardian. Participation 
Page 3 of 8Díaz et al. Malar J  (2015) 14:357 
in the study was voluntary and had no influence on the 
treatment at the health centre. All data is confidential.
PCR analysis and DNA extraction
In line with quality assurance programmes (WHO 
2005), all positive samples by microscopy (736 samples) 
and 10 % of negative microscopy samples were analysed 
by PCR. Since some of the negative microscopy sam-
ples tested positive with PCR, an additional 10  % was 
examined, so that a total of 582 negative samples were 
analysed by PCR, as quality control. 109 samples were 
excluded, which proved to be positive, and 151 negatives 
samples by microscopic diagnosis, owing to the lack of 
filter paper and problems with the numbering; this could 
be considered a limitation of the study by PCR. DNA 
extraction was performed on the filter paper samples 
using commercial kits (Speedtools tissue DNA Extraction 
Kit, Biotools, Spain). The PCR diagnosis is a Semi-nested 
Multiplex PCR, and it was performed, as described by the 
author [16]. The PCR product was subjected to ultravio-
let transilluminator using electrophoresis on 2 % agarose 
gels stained with ethidium bromide.
Sequence analysis of Plasmodium ovale
23 samples diagnosed for P. ovale by PCR were 
sequenced for specific characterization, as P. ovale wal-
likeri or P. ovale curtisi. This was done throughout the 
partial sequencing of the small subunit of ribosomal 
RNA (ssrRNA) gene, with the primers New PLF Sh/New 
Rev Sh [17]. The amplified products were purified with 
the QI Aquick PCR Purification Kit (WERFEN, Spain 
SAU) and sequenced with the big Dye Terminator v3.1 
Cycle Sequencing in an ABI PRISM 3730 Analyser. It is 
necessary for sequencing to have 20 ng of the amplifica-
tion fragment and 5  mM of each primer (forward and 
reverse). All sequences were analysed by free web pages 
[18, 19], and subsequently were compared in GeneBank 
for knowing their identities.
Data‑analysis
It was carried out a descriptive analysis and obtained prev-
alence estimates and their 95 % confidence intervals (CIs) 
through microscopy, PCR diagnoses and sequences results 
(McCallum Layton, Stats Calculator). Sensitivity and spec-
ificity were calculated with the Software Epidat 3.1.
Results
A total of 3060 samples of patients suspected of malaria 
were collected in Bulbula Health Centre, from them 1553 
females and 1507 males, age range 1 month to 80 years 
(mean = 13.4 years; median = 10 years).
Microscopy
From a total of 3060 individuals, 736 (24  %; CI 24.49–
25.51 %) were diagnosed as Plasmodium sp. and 2324 as 
negatives (76  %) for infection by Plasmodium sp. From 
the species detected by microscopy were: 483 samples 
as P. vivax (16  %; 95  % CI 14.7–17.38.96  %), 243 as P. 
Fig. 1 Map of the study area. a Ethiopia map where appears the Oromia Region, and the location of Bulbula, rural area where the study was carried 
out. b Satellite map where appears located Bulbula and lakes that surround it, Ziway Lake, Langano Lake and Abijata Lake, a fact that gives it a pecu-
liar epidemiology of malaria. Images extracted from http://www.es.wikipedia.org/wiki/Orom%C3%ADa and https://www.google.es/maps/
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falciparum (8 %; 95 % CI 7.04–8.96 %), and 10 as mixed 
infections P. falciparum/P. vivax (0.3  %; 95  % CI 0.11–
0.49 %) (Table 1).
PCR
As shown in Table 2, the 736 positive samples by micros-
copy were taken for diagnosis by PCR, but 109 samples 
were excluded due to a lack of filter paper at sampling 
time, an error in numbering or a small amount of blood 
on the filter paper. 627 positive samples were analysed 
(429 P. vivax, 191 P. falciparum, seven P. falciparum/P. 
vivax mixed infections) for the confirmation of species by 
PCR. The process of selection of samples for the diagno-
sis by PCR and its results appear in Fig. 2. 
Regarding the negative samples, it was necessary to 
confirm those diagnosed by microscopy. 10 % of the sam-
ples (306 samples) were selected and were used as control 
microscopy-negative samples. Since a proportion of this 
10 % proved to be positive, a further 10 % of the negative 
samples (276 samples) were analysed. Moreover, of the 
total samples shown to be negative by microscopy (2324), 
151 had to be excluded for the same reasons as before.
After the study of the selected 1209 samples analysed 
by PCR (see Table  3), 321 samples were detected as P. 
falciparum (26.5 %; 95 % CI 24.01–28.99 %), 398 P. vivax 
(33 %; 95 % CI 30.35–35.65 %), 23 P. ovale (2 %; 95 % CI 
1.21–2.79 %), 45 P. falciparum/P. vivax (4 %; 95 % CI 2.9–
5.1 %) and one P. vivax/P. ovale (0.08 %; 95 % CI −0.08 to 
0.24 %) and 421 (35 %; 95 % CI 32.31–37.69 %) negatives 
Table 1 Microscopy results
The table shows the frequency of the different species of Plasmodium sp. and 
negative samples diagnosed by microscopy
Species N % 95 % CI
Plasmodium sp. 736 24 24.49 25.51
P. falciparum 243 8 7.04 8.96
P. vivax 483 16 14.7 17.3
P. falciparum + P. vivax 10 0.3 0.11 0.49
Negatives 2324 76 74.49 77.51
Total 3060 100
Table 2 Reasons for exclusion of the samples













P. vivax 483 9 43 2 54 429
P. falciparum 243 6 41 5 52 191
P. falciparum + P. vivax 10 0 1 2 3 7
Total negatives 2324 6 40 108 151 2173
Total 736 15 85 9 109 627
Fig. 2 Flowchart of sample selection process. The figure shows the 
number of positive samples and negatives diagnosed by microscopy, 
the number of samples no valid for PCR and finally the number of 
samples diagnosed by this technique
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samples. In the group of 627 positive samples by micros-
copy, 23 negative samples were confirmed negative by 
PCR (1.9  %) (i.e. false positives). From the total of 582 
negative samples analysed, 398 samples were negative by 
microscopy (68.4 %; 95 % CI 64.62–72.18 %). The rest of 
the 184 samples were positive for one species (false nega-
tives, 15.2 %), 88 for P. falciparum (15 %; 95 % CI 12.1–
17.9 %), 76 for P. vivax (13 %; 95 % CI 10.27–15.73 %) and 
20 for P. ovale (3.4 %; 95 % CI 1.93–4.87 %). To summa-
rize these results: after removing the 260 samples (109 
positive and 151 negative) of which it was not possible to 
do the diagnostic PCR, we had a total of 2800 samples, 
of which 1209 are used for its confirmation by PCR and 
quality control [627 were positives by microscopy (22.4 %) 
for Plasmodium sp. and 582 negatives (77.6 %)]. From the 
627 positive samples diagnosed by microscopy, 604 were 
confirmed as positive by PCR, therefore 23 false positives 
were detected (see Table 3), and the group of 582 nega-
tive samples selected for quality control of the diagnosis 
by microscopy, 184 were positive by PCR (false negatives, 
15.2 %), which added to the previous positive samples is 
a total of 788 positive samples (28.1 %) for some species 
of Plasmodium sp. It was detected 13.3 % more positives 
with the PCR than the microscopy (see Fig. 3).   
This biggest frequency in the diagnosis by PCR, may 
be due to that 184 samples diagnosed as negatives by 
microscopy were positive (false negatives) after the diag-
nosis by PCR, as shown in Table  3. 88 samples from 
these 184 false negatives, 48  %, were finally diagnosed 
as P. falciparum by PCR. This failure in the diagnosis by 
microscopy could be due to the difficulty of detecting 
parasites by microscopy when in very low density. On the 
other hand, the new data of the frequency of P. falcipa-
rum by PCR fits better with the prevalence official data 
of the country (60 %). After the calculation of specificity 
and sensitivity, PCR as gold standard, the sensitivity was 
76.65  % (95  % CI 73.63–79.67) and specificity of 94.54 
(95 % CI 92.25–96.83), see Table 4.
Sequencing analysis of Plasmodium ovale detected by PCR
The small subunit of ribosomal RNA (rRNA) partial gene 
was amplified and sequenced from the 23 P. ovale samples 
detected by PCR. After sequence analysis and comparison 
with GeneBank, 23 samples detected as P. ovale provded 
to be P. ovale curtisi after the sequencing. Plasmodium 
ovale wallikeri was not detected in the group of samples; 
this does not mean it does not exist in this area of study.
Discussion
This study shows, that in the context of a rural area in 
Ethiopia, the microscopy has low overall sensitivity and 
specificity for the diagnosis of Plasmodium species, 
in fact a new species, Plasmodium ovale spp., has been 
detected in this area.
It is important to emphasize the high number of false 
negatives (184) and false positives (23) detected and the 
impact this has on infection control, as they are patients 
who have not been treated, or they received treatment 
without needing it, and this could facilitate transmis-
sion. This highlights the difficulty of detecting parasites 
Fig. 3 Comparison of the diagnosis by microscopy and PCR. In the first part of the figure appears the comparison between the frequencies of posi-
tive and negative samples diagnosed by microscopy and by PCR. In the second part of the figure shown the comparison between the frequencies 
of each species diagnosed by microscopy and PCR
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by microscopy when it appears a low parasite density. 
An improvement in microscopic diagnosis would pre-
vent both over-treatments of patients and over-exposure 
to anti-malarial drugs. This would help to reducte costs, 
side effects, and most importantly, the risk of emergence 
and spread of drug resistance [20–22]. Furthermore, the 
diagnostic of P. falciparum by microscopy, in both mono-
infection and mixed infections, is low with respect to that 
observed for P. vivax by microscopy. This result is quite 
interesting, in view of the fact that in Ethiopia P. falcipa-
rum is considered the main species, with a prevalence of 
around 60 %, according to official data.
On the other hand, the 38 patients who were diagnosed 
as P. vivax (mono-infection) by microscopy, but who 
were actually co-infected with P. falciparum–P. vivax, 
detected by PCR, were treated with chloroquine (CQ), 
and so they received the wrong treatment.
Plasmodium vivax-infected patients are only treated 
with CQ in accordance with Ethiopian treatment guide-
lines [9]. The use of CQ with primaquine, a tissue schi-
zonticide, would eliminate latent hypnozoites of P. vivax 
in the liver and consequently reduce the possibility of 
recurrences [23]. However, primaquine is not used in this 
area, because the risk of re-infection is very high. Clini-
cians point out that the damage that the primaquine may 
produce is worse than the infection itself.
23 cases of P. ovale were detected by PCR, after the 
sequencing of the small subunit of ribosomal RNA 
(ssRNA) gene of these samples; they were confirmed 
as P. ovale curtisi. However, P. ovale wallikeri was not 
detected. This is an important epidemiological fact, 
because for the first time, a new species of Plasmodium 
has been detected in this area of Ethiopia. The last time 
that P. ovale was reported in Ethiopia was in 1969 [11], 
but it was not until 2013 [13] when the presence of P. 
ovale curtisi and P. ovale wallikeri was published in the 
northwest of Ethiopia. This is the first time P. ovale curtisi 
has been detected in southeastern Ethiopia, in Bulbula, a 
village in the Rift Valley. It is an area with a high malaria 
transmission.
Due to the unavailability of molecular techniques in 
these areas, a good microscopy confirmation method 
would be the rapid diagnostic test of malaria. Despite the 
fact that it does not match the PCR sensitivity, it would 
nevertheless reinforce the results obtained by micro-
scopic diagnosis [20, 24–26]. The introduction of this 
test must be accompanied by adequate training [27, 28]. 
Taking into account the results obtained in the study, 
it would be desirable to provide training and updated 
courses on malaria to improve the microscopic identifica-
tion of Plasmodium species in rural health centres, where 
scarcity of resources is greater than in other places.
Although Ethiopia has some reference laboratories for 
infectious diseases in different regions, a major challenge 
facing the country is to establish more direct contacts 
between rural areas and these reference laboratories, 
where molecular techniques could be standardized and 
thus to support the microscopic diagnosis in rural areas, 
in addition to perform a quality control of diagnosis 
methods. These reference laboratories could perform 
prevalence and drug-resistance studies; as is done in 
some regions of Ethiopia [29]. It would be necessary to 
extend this kind of studies to all regions, which would 
allow to obtain more reliable epidemiological data.
Conclusions
The analysis by PCR of the samples collected in Bulbula 
(south-eastern Ethiopia), has detected more positives 
samples for malaria than the diagnosis by microscopy 
made in this health centre, which could have serious 
effects on infection control. Throughout the diagnosis 
by PCR and subsequent sequencing, P. ovale curtisi was 
detected for the first time in this area. In view of the 
results obtained in diagnostic microscopy, it would be 
good to provide training and update courses for malaria 
diagnosis regularly, to improve the quality of diagnosis. 
In addition, it would also be advisable for these health 
centres to have another confirmation technique, such as 
rapid diagnostic tests for malaria.
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